General Information
Version
1.0 en
Revision date
2025-03-10
Product name
Naproxen ≥95 %
CAS No.
22204-53-1
REACH No
It
1.2.1 Relevant identified uses
Laboratory and analytical use
1.2.2. Uses advised against
Do not use for products which come into contact with foodstuffs. Do not use for private purposes (household). Food, drink and animal feeding- stuffs
Emergency telephone
+49/(0)89 19240
Icons in SDS
Company Information
company name
Carl Roth GmbH + Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
sicherheit@carlroth.de
GHS Information
Signal word
Not required
Hazard Codes
Hazard statements (CLP)
H302, H315, H319, H335, H361
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No 1272/2008 [CLP Classification of the substance or mixture
Hazard categories
Cat- Hazard class and Hazard egory category statement 3.1O Acute toxicity (oral) Acute Tox. 4 H302 3.2 Skin corrosion/irritation Skin Irrit. 2 H315 3.3 Serious eye damage/eye irritation Eye Irrit. 2 H319 Section Cat- Hazard class and Hazard egory category statement 3.7 Reproductive toxicity Repr. 2 H361 3.8R Specific target organ toxicity - single exposure (respir- STOT SE 3 H335 atory tract irritation) For full text of abbreviations: see SECTION 16
Signal word
Warning Not required
Hazard pictograms
GHS07, GHS08 H335 May cause respiratory irritation. H361 Suspected of damaging fertility or the unborn child. Labelling of packages where the contents do not exceed 10 ml
Hazard statements
H302 Harmful if swallowed H315 Causes skin irritation H319 Causes serious eye irritation H335 May cause respiratory irritation H361 Suspected of damaging fertility or the unborn child For professional users only Labelling of packages where the contents do not exceed 125 ml Not required
Precautionary statements
Not required
Results of PBT and vPvB assessment
According to the results of its assessment, this substance is not a PBT or a vPvB. Endocrine disrupting properties Does not contain an endocrine disruptor (ED) at a concentration of ≥ 0,1%.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 (CLP) Section Hazard class Cat- Hazard class and Hazard egory category statement 3.1O Acute toxicity (oral) 4 Acute Tox. 4 H302 3.2 Skin corrosion/irritation 2 Skin Irrit. 2 H315 3.3 Serious eye damage/eye irritation 2 Eye Irrit. 2 H319 Section Hazard class Cat- Hazard class and Hazard egory category statement 3.7 Reproductive toxicity 2 Repr. 2 H361 3.8R Specific target organ toxicity - single exposure (respir- 3 STOT SE 3 H335 atory tract irritation) For full text of abbreviations: see SECTION 16
